A client with end-stage renal disease (ESRD) is receiving erythropoietin-stimulating agents (ESAs) as part of the dialysis treatment. Which of the following statements by the client indicates an understanding of the medication's purpose?

A) This statement is incorrect. Dialysis does not restore normal kidney function. Instead, it serves as a substitute for impaired kidney function, helping to maintain fluid and electrolyte balance.

B) This statement is incorrect. Dialysis is not a surgical procedure to transplant a healthy kidney. Kidney transplantation is a separate procedure that involves replacing a damaged kidney with a healthy one from a living or deceased donor.

C) This statement is incorrect. Dialysis may help manage complications of CKD and prolong life, but it does not prevent the progression of the underlying kidney disease. CKD is a chronic and progressive condition that may eventually require dialysis or kidney transplantation.

D) This statement is accurate. Dialysis is the process of removing waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions adequately.

A. Incorrect. While administering an antiepileptic medication may be necessary if the client is experiencing seizures, it is essential to identify the underlying cause first.

B. Correct. The client's severe headache, confusion, and seizures may be indicative of dialysis disequilibrium syndrome, which is a complication of rapid solute removal during hemodialysis. Hypoglycemia can also present with similar symptoms, so assessing blood glucose levels is crucial to differentiate between the two conditions.

C. Incorrect. Documenting the findings and monitoring the client's condition are important, but addressing the acute symptoms and potential cause should be the priority.

D. Incorrect. Checking the client's pre-dialysis weight is not the priority when the client is experiencing severe neurological symptoms. Immediate assessment and intervention are needed.